Drugs / 89Zr-Oxine-RY_SW01 Cell Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06489652 | Jun 2024 → May 2025 overdue | systemic sclerosis | Jiangsu Renocell Biotech Company | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 89Zr-Oxine-RY_SW01 Cell Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06489652 ↗ |